To screen or not to screen adults 45-49 years of age: That is the question

American Journal of Gastroenterology

Volumn 113, Issue 12, 2018, Pages 1750-1753

  Anderson, Joseph C ^a,b   Samadder, N Jewel ^c  

^a DARTMOUTH COLLEGE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AWARENESS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER STAGING; COLONOSCOPY; COLORECTAL CANCER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HIGH RISK POPULATION; HUMAN; PATIENT COMPLIANCE; POLYPECTOMY; PRIORITY JOURNAL; REVIEW; AGE; COLORECTAL TUMOR; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; ECONOMICS; INCIDENCE; MASS SCREENING; MIDDLE AGED; NON PROFIT ORGANIZATION; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PROCEDURES; STANDARDS; UNITED STATES;

AGE FACTORS; AMERICAN CANCER SOCIETY; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVENTIVE HEALTH SERVICES; UNITED STATES;

EID: 85056142019     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/s41395-018-0402-3     Document Type: Review

References (32)

1. Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177-93.
2. Siegel RL, Miller KD, Jemal A. Colorectal cancer mortality rates in adults aged 20 to 54 years in the United States, 1970-2014. JAMA. 2017;318:572-4.
3. Welch HG, Robertson DJ. Colorectal cancer on the decline-why screening can't explain it all. N Engl J Med. 2016;374:1605-7.
4. Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl Cancer Inst. 2017;109.
5. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68:250-81.
6. Katki HA, Kovalchik SA, Berg CD, et al. Development and validation of risk models to select ever-smokers for CT lung cancer screening. JAMA. 2016;315:2300-11.
7. Knudsen AB, Zauber AG, Rutter CM, et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: Modeling study for the US Preventive Services Task Force. JAMA. 2016;315:2595-609.
8. Peterse EFP, Meester RGS, Siegel RL, et al. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline. Cancer. 2018;124:2964-73.
9. Surveillance E, Program ER. (www.seer.cancer.gov) SEER∗ Stat Database: Mortality-All COD, Aggregated With State, Total US (1969-2010). 2015.
10. Surveillance, Epidemiology, and End Results (SEER) Program (www. seer.cancer.gov) SEER∗Stat Database: Incidence-SEER 9 Regs Research Data with Delay-Adjustment, Malignant Only, Nov 2017 Sub (1975-2015) < Katrina/Rita Population Adjustment > - Linked to County Attributes-Total U.S., 1969-2016 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2018, based on the November 2017 submission.
11. Joseph DA, Meester RG, Zauber AG, et al. Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacity. Cancer. 2016;122:2479-86.
12. Levin TR, Zhao W, Conell C, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006;145:880-6.
13. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977-81.
14. Patel SG, Ahnen DJ. Colorectal cancer in the young. Curr Gastroenterol Rep. 2018;20:15.
15. You YN, Xing Y, Feig BW, et al. Young-onset colorectal cancer: Is it time to pay attention? Arch Intern Med. 2012;172:287-9.
16. Dozois EJ, Boardman LA, Suwanthanma W, et al. Young-onset colorectal cancer in patients with no known genetic predisposition: Can we increase early recognition and improve outcome? Medicine (Baltimore). 2008;87:259-63.
17. Teng A, Lee DY, Cai J, et al. Patterns and outcomes of colorectal cancer in adolescents and young adults. J Surg Res. 2016;205:19-27.
18. Lieberman DA, Williams JL, Holub JL, et al. Colonoscopy utilization and outcomes 2000 to 2011. Gastrointest Endosc. 2014;80:133-43.
19. Austin H, Henley SJ, King J, et al. Changes in colorectal cancer incidence rates in young and older adults in the United States: what does it tell us about screening. Cancer Causes Control. 2014;25:191-201.
20. Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomark Prev. 2009;18:1695-8.
21. Chen FW, Sundaram V, Chew TA, et al. Advanced-stage colorectal cancer in persons younger than 50 years not associated with longer duration of symptoms or time to diagnosis. Clin Gastroenterol Hepatol. 2017;15:728-37 e3.
22. Karlitz JJ, Oliphant AB, Greenwald DA, et al. The American College of Gastroenterology and the 80% by 2018 Colorectal Cancer Initiative: A multifaceted approach to maximize screening rates. Am J Gastroenterol. 2017;112:1360-2.
23. Stryker SJ, Wolff BG, Culp CE, et al. Natural history of untreated colonic polyps. Gastroenterology. 1987;93:1009-13.
24. Qaseem A, Denberg TD, Hopkins RH Jr., et al. Screening for colorectal cancer: A guidance statement from the American College of Physicians. Ann Intern Med. 2012;156:378-86.
25. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104:739-50.
26. Institute for Clinical Systems Improvement. Health care guideline: Colorectal cancer screening. 2010. www.icsi.org/colorectal_cancer_screening/ colorectal_cancer_screening_5.html.
27. Hadjipetrou A, Anyfantakis D, Galanakis CG, et al. Colorectal cancer, screening and primary care: A mini literature review. World J Gastroenterol. 2017;23:6049-58.
28. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-86.
29. Kastrinos F, Steyerberg EW, Balmana J, et al. Comparison of the clinical prediction model PREMM(1, 2, 6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Gut. 2013;62:272-9.
30. Tammana VS, Laiyemo AO. Colorectal cancer disparities: Issues, controversies and solutions. World J Gastroenterol. 2014;20:869-76.
31. Ballester V, Rashtak S, Boardman L. Clinical and molecular features of young-onset colorectal cancer. World J Gastroenterol. 2016;22:1736-44.
32. Ahnen DJ, Wade SW, Jones WF, et al. The increasing incidence of young-onset colorectal cancer: A call to action. Mayo Clin Proc. 2014;89:216-24.